Answers are grounded in this paper and cite their sources.
A novel formulation (IL-NP) for the transdermal delivery of nucleic acid medicines was developed using biocompatible ionic liquid (IL).
No takes yet. Share an insight, caveat, or question.
Toyofuku et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: